BMJ 2005;331:856-857 (15 October), doi:10.1136/bmj.331.7521.856
Editorial
Complementary therapies and the NHS
Uncertain evidence of cost effectiveness should not exclude complementary medicine from reviews and guidelines
| The first 150 words of the full text of this article appear below. |
In the early 20th century, scientific medicine emerged as the dominant model for health care in the West. Yet, despite the successes of scientific medicine, people have continued to seek treatments outside mainstream services.1 In the United Kingdom about one in 10 of the adult population consults a CAM (complementary and alternative medicine) practitioner every year, and 90% of this contact happens outside the NHS.2
Why do people turn to these therapies? Persistent symptoms and the real or perceived adverse effects of conventional treatments are the main reasons.w1 Patients value complementary practitioners viewing their predicament "as a whole" and not through the fragmenting lens of clinical specialisation or within the time pressured environment of primary care.w2
The popularity of a clinical method should not, however, be confused with its value. The popularity of CAM may simply reflect the limitations of conventional treatments. In the past 20 years there has . . . [Full text of this article]
Trevor Thompson, clinical lecturer
Academic Unit of Primary Care, University of Bristol, Bristol BS6 6JL
Gene Feder, professor of primary care research and development
Centre for Health Sciences, Barts and the London, Queen Mary's School of Medicine and Dentistry, London E1 4AT (g.s.feder@qmul.ac.uk)

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Relevant Articles
-
CAM before the storm: authors' reply
- Trevor D Thompson and Gene Feder
BMJ 2005 331: 1205.
[Extract]
[Full Text]
-
Scientific evidence was ignored in CAM and the NHS
- Peter H Canter and Edzard Ernst
BMJ 2005 331: 1024.
[Extract]
[Full Text]
-
New GP network will integrate conventional and complementary medicine
- Kathryn Godfrey
BMJ 2005 331: 924.
[Extract]
[Full Text]
-
Keep politics out of it
- Fiona Godlee
BMJ 2005 331: 0.
[Extract]
[Full Text]
[PDF]
-
Cost effectiveness of complementary treatments in the United Kingdom: systematic review
- Peter H Canter, Joanna Thompson Coon, and Edzard Ernst
BMJ 2005 331: 880-881.
[Full Text]
[PDF]
-
Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine
- A Szegedi, R Kohnen, A Dienel, and M Kieser
BMJ 2005 330: 503.
[Abstract]
[Full Text]
[PDF]
-
Framework for design and evaluation of complex interventions to improve health
- Michelle Campbell, Ray Fitzpatrick, Andrew Haines, Ann Louise Kinmonth, Peter Sandercock, David Spiegelhalter, and Peter Tyrer
BMJ 2000 321: 694-696.
[Extract]
[Full Text]
[PDF]
This article has been cited by other articles:
-
van den Meerschaut, L., Sunder, A.
(2007). The Homeopathic Preparation Nervoheel N can Offer an Alternative to Lorazepam Therapy for Mild Nervous Disorders. Evid Based Complement Alternat Med
0: nem144v1-nem144
[Abstract]
[Full text]
-
Thompson, T. D, Feder, G.
(2005). CAM before the storm: authors' reply. BMJ
331: 1205-1205
[Full text]
-
Canter, P. H, Ernst, E.
(2005). Scientific evidence was ignored in CAM and the NHS. BMJ
331: 1024-1024
[Full text]
Rapid Responses:
Read all Rapid Responses
- The unwelcome report
- Balaji Ravichandran
bmj.com, 14 Oct 2005
[Full text]
- Rigour, Reviews and Clinical Guidlines
- Janet Richardson
bmj.com, 14 Oct 2005
[Full text]
- Caution to the winds
- Satya V Chelamkuri
bmj.com, 15 Oct 2005
[Full text]
- Excessive Sterility Perhaps
- Ned Hoke
bmj.com, 15 Oct 2005
[Full text]
- Scientific evidence ignored
- Peter H Canter, et al.
bmj.com, 17 Oct 2005
[Full text]
- Asthma, Yoga and the safety of conventional treatment
- Frank J Leavitt
bmj.com, 19 Oct 2005
[Full text]
- Complementary therapies and the NHS
- Nicola Robinson
bmj.com, 21 Oct 2005
[Full text]
- Cost-Effectiveness of Complementary and Alternative Medicine: Not to be seen in isolation
- Anandagiri M Shankar, et al.
bmj.com, 26 Oct 2005
[Full text]
- CAM before the storm
- Trevor D Thompson, et al.
bmj.com, 26 Oct 2005
[Full text]
- Pragmatic clinical trials for CAM have strengths and weaknesses
- Vincent Chung, et al.
bmj.com, 26 Oct 2005
[Full text]
- Getting the words right
- Peter M Lapsley
bmj.com, 20 Dec 2005
[Full text]